Order Article Reprints

Cegolon L, Mastrangelo G, Emanuelli E, Camerotto R, Spinato G, Frezza D. Early Negativization of SARS-CoV-2 Infection by Nasal Spray of Seawater plus Additives: The RENAISSANCE Open-Label Controlled Clinical Trial. Pharmaceutics. 2022; 14(11):2502. https://doi.org/10.3390/pharmaceutics14112502

Cegolon, Luca, Giuseppe Mastrangelo, Enzo Emanuelli, Riccardo Camerotto, Giacomo Spinato, and Daniele Frezza. 2022. "Early Negativization of SARS-CoV-2 Infection by Nasal Spray of Seawater plus Additives: The RENAISSANCE Open-Label Controlled Clinical Trial" Pharmaceutics 14, no. 11: 2502. https://doi.org/10.3390/pharmaceutics14112502

Cegolon, L., Mastrangelo, G., Emanuelli, E., Camerotto, R., Spinato, G., & Frezza, D. (2022). Early Negativization of SARS-CoV-2 Infection by Nasal Spray of Seawater plus Additives: The RENAISSANCE Open-Label Controlled Clinical Trial. Pharmaceutics, 14(11), 2502. https://doi.org/10.3390/pharmaceutics14112502